Through our regular conferences and workshops, we bring together stakeholders in childhood cancer treatment and research to exchange knowledge and ideas.
We aim to provide a forum for clinicians, scientists and other stakeholders to discuss and debate key themes, share knowledge and develop new collaborations.
Our recent conference
Childhood Cancer 2016: A scientific and educational meeting showcasing state-of-the-art translational science in childhood cancer
5th to 7th September 2016 at Church House Conference Centre, London
We were joined by an outstanding line-up of speakers from the UK, Europe and the US to examine three themes over the three days of the conference:
- Is precision medicine a reality for children with cancer in 2016?
- Can we harness the power of the immune system to cure childhood cancer?
- What do we know about influenceable causes of childhood cancer?
The format of the meeting was designed to facilitate the sharing of information and knowledge, providing a forum for the discussion of important issues, networking and the development of new collaborations.
In total, around 150 delegates and speakers participated in the meeting over the three days and we achieved our aim of bringing together a broad range of scientists and clinicians from different areas of childhood cancer research and care.
Conference materials including video footage and interviews with speakers will be available shortly on the conference website:
Visit the Childhood Cancer 2016 website
Future conferences and workshops
Planning is underway for Childhood Cancer 2017, which will take place in the autumn of 2017.
Childhood Cancer 2017 will be a two-day meeting focused on translational research for patient benefit. Further details will be published shortly.
Email email@example.com to be kept informed of plans for Childhood Cancer 2017 and other research news.
Previous conferences and workshops
Drug delivery in paediatric brain tumours
1st and 2nd February 2016 at the Royal College of Physicians, London
This workshop, chaired by Professor David Walker, was developed to highlight the priority of drug delivery research and clinical trials as part of initiatives to improve outcomes for children with brain tumours.
We wanted to identify areas of pre-clinical and clinical research that can be pursued now, with a view to early translation into clinical trials, to identify drug delivery strategies holding promise for future deployment and to identify optimal development pathways for their translation to clinical trials.
With colleagues joining us from the US, Canada and Europe to share their expertise and experience, we enjoyed two days of lively discussion. A report has been published by ecancer, along with interviews with some of our speakers:
View speaker interviews and access the report on ecancer
Read more: Our Brain Tumour Workshop blog
Think Tank on: Magnetic fields and childhood leukaemia - candidate mechanistic pathways
London, 22nd and 23rd September 2014
An association between exposure to magnetic fields linked to the electricity supply above average levels of 0.3/0.4 microtesla and childhood leukaemia risk is widely acknowledged in official EMF Reports. However, the mechanism(s) by which magnetic fields may increase the risk of leukaemia are unclear.
This Think Tank brought together world experts on leading-edge aspects of the interaction of magnetic fields with biological systems to brainstorm candidate mechanisms.
Participants were provided with a unique opportunity to exchange the latest advances in understanding, across otherwise diverse specialist topics.
Download the full report: Magnetic fields and childhood leukaemia – candidate mechanistic pathways
Workshop on in utero exposure and cancer in children
2nd and 3rd June 2014 at the Royal College of Physicians, London
The initiating event(s) in at least some childhood cancers is believed to occur in utero. This two-day international workshop set out to examine aspects of in utero exposure to agents that may affect subsequent cancer risk in children, with an emphasis on mechanisms of transplacental transfer and early biological effects.
Speakers and delegates travelled from far and wide to take part in the workshop and contributed enthusiastically. We built in a generous amount of discussion time to enable a two-way flow of information.
Participants welcomed the opportunity to share knowledge and ideas with those working in allied fields and we know that several new collaborations have already been born.
Download the full report of the event: In utero exposure and cancer in children
Childhood Cancer 2012: International scientific conference on Early Exposures and Childhood Cancer
In April 2012 over 150 participants from around the world joined us in London for Childhood Cancer 2012, our international scientific conference on the causes of childhood cancer.
The conference was opened by Professor Sir Alan Craft, former president of Royal College of Paediatrics and one of the UK’s leading experts on childhood medicine.
Over the three days that followed, delegates heard from more than 20 international experts speaking across a wide-range of topics relevant to the causes of childhood cancer including air pollution, parental smoking, pesticide exposure, genetics and diet.
Read more: Childhood Cancer 2012 – conference summary
Stay in touch
If you would like to be kept informed about future events, funding opportunities and other research news, please email firstname.lastname@example.org to join our mailing list.